Home Therapy Infections in HIV / cellular immune disorders
Home Therapy Infections in HIV / cellular immune disorders

CMV retinitis

Advices

≥ 18 years
Priority Medication Remarks
Priority:
 1st choice 		Medication:

valganciclovir po 900mg 2dd minimum 14 days
Remarks:

SWAB remarks

Milde gevallen
Priority:
 1st choice alternative 		Medication:

ganciclovir iv 5mg/kg 2dd minimum 14 days
Priority:
 2nd choice 		Medication:

foscarnet iv 90mg/kg 2dd minimum 14 days

General comments

Bij betrokkenheid macula: ganciclovir iv + intravitreale injectie ganciclovir: initiele injectie is 4mg/0,1mL, vervolg injecties zijn 2mg/0,1mL tot klinische remissie.

Bij resistentie tegen ganciclovir: foscarnet iv + intravitreale injectie foscarnet 2.4mg/0.1mL.

Na behandeling secundaire profylaxe: 

  • valganciclovir po 900mg 1dd tenminste 3 mnd
  • Bij resistentie tegen ganciclovir: overleg over secundaire profylaxe en overweeg foscarnet iv 90mg/kg 1dd

Sources

  1. clinicalinfo.hiv.gov/CMV

    DHHS Guidelines (NIH)

Antimicrobial resources

The following antimicrobial agents have been used in these recommendations:

External antimicrobial resources
Menu position
Metadata

Swab vid: G-8248.3
Updated: 03/24/2025 - 11:55
Status: Published